These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 23248849)

  • 1. [Genetic determinancy of the change in the VE-cadherin expression and intensified vessel deendothelisation at hemorrhagic fever with renal syndrome].
    Baĭgil'dina AA; Islamgulov DV
    Mol Gen Mikrobiol Virusol; 2012; (4):23-7. PubMed ID: 23248849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Probable sources of endothelial cells circulating in blood].
    Baĭgil'dina AA; Lebedeva AI; Vagapova VSh
    Morfologiia; 2011; 139(3):58-62. PubMed ID: 21954710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased levels of soluble vascular endothelial cadherin are associated with poor outcome in severe sepsis.
    Zhang RY; Liu YY; Li L; Cui W; Zhao KJ; Huang WC; Gu XW; Liu W; Wu J; Min D; Mao EQ; Tang YQ
    J Int Med Res; 2010; 38(4):1497-506. PubMed ID: 20926024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrostatic pressure influences morphology and expression of VE-cadherin of vascular endothelial cells.
    Ohashi T; Sugaya Y; Sakamoto N; Sato M
    J Biomech; 2007; 40(11):2399-405. PubMed ID: 17261311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TAL-1/SCL and its partners E47 and LMO2 up-regulate VE-cadherin expression in endothelial cells.
    Deleuze V; Chalhoub E; El-Hajj R; Dohet C; Le Clech M; Couraud PO; Huber P; Mathieu D
    Mol Cell Biol; 2007 Apr; 27(7):2687-97. PubMed ID: 17242194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial VE-cadherin expression in human lungs.
    Herwig MC; Müller KM; Müller AM
    Pathol Res Pract; 2008; 204(10):725-30. PubMed ID: 18639387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosine phosphorylation of VE-cadherin and claudin-5 is associated with TGF-β1-induced permeability of centrally derived vascular endothelium.
    Shen W; Li S; Chung SH; Zhu L; Stayt J; Su T; Couraud PO; Romero IA; Weksler B; Gillies MC
    Eur J Cell Biol; 2011 Apr; 90(4):323-32. PubMed ID: 21168935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and morphological parallels in lung lesions associated with hemorrhagic fever with renal syndrome].
    Mukhetdinova GA; Fazlyeva RM; Mustafina VKh; Nelubin EV; Evdokimov EV; Kuchina TA; Shchekin SV
    Klin Med (Mosk); 2012; 90(5):17-20. PubMed ID: 22993944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenesis: the VE-cadherin switch.
    Wallez Y; Vilgrain I; Huber P
    Trends Cardiovasc Med; 2006 Feb; 16(2):55-9. PubMed ID: 16473763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet glycoprotein IIb/IIIa (HPA-1 and HPA-3) polymorphisms in patients with hemorrhagic fever with renal syndrome.
    Liu Z; Gao M; Han Q; Lou S; Fang J
    Hum Immunol; 2009 Jun; 70(6):452-6. PubMed ID: 19286442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac ischemia activates vascular endothelial cadherin promoter in both preexisting vascular cells and bone marrow cells involved in neovascularization.
    Kogata N; Arai Y; Pearson JT; Hashimoto K; Hidaka K; Koyama T; Somekawa S; Nakaoka Y; Ogawa M; Adams RH; Okada M; Mochizuki N
    Circ Res; 2006 Apr; 98(7):897-904. PubMed ID: 16543497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hantavirus nephropathy.
    Ferluga D; Vizjak A
    J Am Soc Nephrol; 2008 Sep; 19(9):1653-8. PubMed ID: 18650483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired VE-cadherin/beta-catenin expression mediates endothelial cell degeneration in dilated cardiomyopathy.
    Schäfer R; Abraham D; Paulus P; Blumer R; Grimm M; Wojta J; Aharinejad S
    Circulation; 2003 Sep; 108(13):1585-91. PubMed ID: 12963640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing tumor angiogenesis: increased circulating VE-cadherin RNA in patients with cancer indicates viability of circulating endothelial cells.
    Rabascio C; Muratori E; Mancuso P; Calleri A; Raia V; Foutz T; Cinieri S; Veronesi G; Pruneri G; Lampertico P; Iavarone M; Martinelli G; Goldhirsch A; Bertolini F
    Cancer Res; 2004 Jun; 64(12):4373-7. PubMed ID: 15205354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ETS1 lowers capillary endothelial cell density at confluence and induces the expression of VE-cadherin.
    Lelièvre E; Mattot V; Huber P; Vandenbunder B; Soncin F
    Oncogene; 2000 May; 19(20):2438-46. PubMed ID: 10828886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site.
    Wallez Y; Cand F; Cruzalegui F; Wernstedt C; Souchelnytskyi S; Vilgrain I; Huber P
    Oncogene; 2007 Feb; 26(7):1067-77. PubMed ID: 16909109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VE-cadherin increases the half-life of VEGF receptor 2.
    Calera MR; Venkatakrishnan A; Kazlauskas A
    Exp Cell Res; 2004 Oct; 300(1):248-56. PubMed ID: 15383331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tumour necrosis factor-alpha induced vascular permeability is associated with a reduction of VE-cadherin expression.
    Hofmann S; Grasberger H; Jung P; Bidlingmaier M; Vlotides J; Janssen OE; Landgraf R
    Eur J Med Res; 2002 Apr; 7(4):171-6. PubMed ID: 12010652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stent coated with antibody against vascular endothelial-cadherin captures endothelial progenitor cells, accelerates re-endothelialization, and reduces neointimal formation.
    Lim WH; Seo WW; Choe W; Kang CK; Park J; Cho HJ; Kyeong S; Hur J; Yang HM; Cho HJ; Lee YS; Kim HS
    Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):2798-805. PubMed ID: 22015656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of VE-cadherin correlates temporally with differentiation of a restrictive endothelial barrier during normal angiogenesis in vivo.
    Cruz A; DeFouw DO
    Tissue Cell; 1999 Dec; 31(6):545-9. PubMed ID: 10669929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.